The Impact of Focused Transthoracic Echocardiography in Urgent Abdominal Surgery for Septic Patients (ECHOCARD)
The Impact of Extended Hemodynamic Monitoring by Focused Transthoracic Echocardiography in Urgent Abdominal Surgery for Septic Patients
調査の概要
詳細な説明
Often sepsis remains undiagnosed at the very beginning because of the concentration to the surgical pathology in perioperative period. This results in unacceptably high mortality. The investigators hypothesize that extended hemodynamic monitoring by focused transthoracic echocardiography will personalize early fluid resuscitation which will improve patient's outcome.
The goals of the investigators study are:
- To conduct two-group randomized controlled clinical trial to compare patient management based on standard monitoring and extended hemodynamic monitoring by focused transthoracic echocardiography in patients undergoing urgent abdominal surgery due to peritonitis.
- To demonstrate that patient management based on extended hemodynamic monitoring by focused echocardiography results in improved survival, reduced incidence of hemodynamic instability during perioperative period.
- To compare an amount of administrated of intravenous fluids in both groups.
The investigators hypothesize that focused echocardiography monitoring will result in more administrated intravenous fluids during perioperative period.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
A. Mickeviciaus Street 9
-
Kaunas、A. Mickeviciaus Street 9、リトアニア、LT-44307
- Lithuanian university of health sciencies
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Age more than 18 years old.
- Patients undergoing urgent abdominal surgery due to diffuse peritonitis.
- SOFA score >2.
- Patients who sign an agreement to participate in the study.
Exclusion Criteria:
- Younger than 18 years old.
- Known pregnancy.
- Unconscious patients or those who do not agree to participate in the study.
- Contraindication to central venous or arterial catheterization.
- Patients who were already treated in ICU because of sepsis or septic shock before this surgery.
- Known chronic renal failure.
- Re-laparotomy.
- Peritonitis due to acute mesenteric ischaemia, thrombosis or trauma.
- Dying patients.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:Non-echo group
Patients get the standard monitoring and treatment based on Good medical practice.
Extended monitoring by focused echocardiography is not applied for this group.
|
|
|
実験的:Focussed echocardiography group
The extended cardiac monitoring by focused assessed transthoracic echocardiography is applied.
|
Focused assessed transthoracic echocardiography is non-invasive, painless procedure.
The transducer is placed on the chest at certain locations and angles to get the required information on patient's condition.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Inpatient mortality in both treatment arms.
時間枠:30 days intra-hospital mortality
|
Comparison of 30 days intra-hospital mortality in both arms.
|
30 days intra-hospital mortality
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Comparison of incidence of severe hypotension MAP <65 mmHg after anaesthesia induction in both arms.
時間枠:1-5 minutes after anaesthesia induction.
|
To evaluate the incidence of severe hypotension after anesthesia induction (1 - 5 minutes after induction) in both groups.
|
1-5 minutes after anaesthesia induction.
|
|
Comparison of fluid management in both arms (from hospitalisation to the surgery, during the surgery, after the surgery up to 24 hours).
時間枠:up to 24 hours
|
Comparison of tow fluids management strategies.
Usual monitoring group - fluid management based on fluid responsiveness based by clinical sings.
FATE group - fluid management based on focused transthoracic echocardiography data.
|
up to 24 hours
|
|
Comparison of septic shock incidence in both arms.
時間枠:up to 30 days
|
To compare the manifestation of septic shock (hemodynamics instability not responding to fluid administration, which requires norepinephrine infusion to maintain MAP ≥ 65 mmHg);
|
up to 30 days
|
|
Number of ICU-Free days.
時間枠:up to 30 days
|
To compare ICU free days in both groups.
|
up to 30 days
|
協力者と研究者
捜査官
- スタディチェア:Andrius Macas, profesor、Lithuanian university of health sciencies
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。